For the quarter ending 2025-10-31, BCTXZ has $13,075,050 in assets. $2,714,012 in cash and cash equivalents.
| Balance Sheets | 2025-10-31 | 2025-07-31 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 2,714,012 | 10,493,808 | ||
| Short-term investments | 7,461,960 | 7,372,473 | ||
| Amounts receivable and prepaid expenses | 1,172,435 | 2,060,295 | ||
| Total current assets | 11,348,407 | 19,926,576 | ||
| Equity investment in bc therapeutics | 554,448 | 524,278 | ||
| Intangible assets, net | 180,707 | 184,525 | ||
| Property and equipment, net | 273,980 | 296,819 | ||
| Long term prepaid expenses | 717,508 | 717,508 | ||
| Total non-current assets | 1,726,643 | 1,723,130 | ||
| Total assets | 13,075,050 | 21,649,706 | ||
| Trade payables | 2,128,915 | 3,283,703 | ||
| Accrued expenses and other payables | 1,188,858 | 694,285 | ||
| Total current liabilities | 3,317,773 | 3,977,988 | ||
| Warrant liability | 406,873 | 337,672 | ||
| Total non-current liabilities | 406,873 | 337,672 | ||
| Share capital of no par value authorized unlimited at october 31, 2025 and july 31, 2025 issued and outstanding 1,883,906 shares at october 31, 2025 and july 31, 2025, respectively | 101,739,923 | 101,739,923 | ||
| Share-based payment reserved | 10,610,826 | 10,316,140 | ||
| Warrant reserve | 17,719,026 | 17,719,026 | ||
| Accumulated other comprehensive loss | -138,684 | -138,684 | ||
| Non-controlling interest | -627,558 | -546,795 | ||
| Accumulated deficit | -119,953,129 | -111,755,564 | ||
| Total shareholders equity | 9,350,404 | 17,334,046 | ||
| Total liabilities and shareholders equity | 13,075,050 | 21,649,706 | ||
BriaCell Therapeutics Corp. (BCTXZ)
BriaCell Therapeutics Corp. (BCTXZ)